Research Article
A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease
Table 1
A list of bioactive compounds of EZP for network analysis.
| Mol ID | Molecule name | MW | OB (%) | DL | Pubchem ID | Herb |
| MOL000006 | Luteolin | 286.25 | 36.16 | 0.25 | 5280445 | LLF/EH | MOL000098 | Quercetin | 302.25 | 46.43 | 0.28 | 5280343 | LLF/EH | MOL000263 | Oleanolic acid | 456.78 | 29.02 | 0.76 | 10494 | LLF | MOL000358 | Beta-sitosterol | 414.79 | 36.91 | 0.75 | 222284 | LLF | MOL000422 | Kaempferol | 286.25 | 41.88 | 0.24 | 5280863 | LLF | MOL002929 | Salidroside | 300.34 | 7.01 | 0.20 | 159278 | LLF | MOL004576 | Taxifolin | 304.27 | 57.84 | 0.27 | 439533 | LLF | MOL005146 | Lucidumoside D | 568.63 | 48.87 | 0.71 | 10531060 | LLF | MOL005147 | Lucidumoside D_qt | 406.47 | 54.41 | 0.47 | — | LLF | MOL005169 | (20S)-24-ene-3β,20-diol-3-acetate | 486.86 | 40.23 | 0.82 | 185500 | LLF | MOL005188 | Specnuezhenide | 686.73 | 19.30 | 0.50 | 91895359 | LLF | MOL005190 | Eriodictyol | 288.27 | 71.79 | 0.24 | 440735 | LLF | MOL005195 | Syringaresinol diglucoside_qt | 450.48 | 83.12 | 0.8 | 21603207 | LLF | MOL005209 | Lucidusculine | 401.6 | 30.11 | 0.75 | 101286217 | LLF | MOL005211 | Olitoriside | 696.87 | 65.45 | 0.23 | 94348 | LLF | MOL005212 | Olitoriside_qt | 404.55 | 103.23 | 0.78 | — | LLF | MOL001689 | Acacetin | 284.28 | 34.97 | 0.24 | 5280442 | EH | MOL001790 | Linarin | 592.6 | 39.84 | 0.71 | 5317025 | EH | MOL002975 | Butin | 272.27 | 69.94 | 0.21 | 28125525 | EH | MOL003389 | 3-O-Methylorobol | 300.28 | 57.41 | 0.27 | 5489605 | EH | MOL003398 | Pratensein | 299.27 | 39.06 | 0.28 | 5319744 | EH | MOL003402 | Demethylwedelolactone | 302.25 | 72.13 | 0.43 | 5281803 | EH | MOL003404 | Wedelolactone | 314.26 | 49.6 | 0.48 | 5281813 | EH |
|
|